Psoriasis and psoriatic arthritis: separate or one and the same? (Q36921661)

17 August 2017

1 reference

title

Psoriasis and psoriatic arthritis: separate or one and the same? (English)

1 reference

17 August 2017

1 reference

Ciocon DH

1

1 reference

17 August 2017

Kimball AB

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

24 August 2007

1 reference

British Journal of Dermatology

17 August 2017

published in

1 reference

17 August 2017

volume

157

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

850-860

1 reference

Psoriatic arthritis: a unified concept twenty years on.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Diagnosis and treatment of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Assessment of patients with psoriatic arthritis: a review of currently available measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Classification and diagnostic criteria for psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Relationship of psoriatic arthritis with the other spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Epidemiology of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Epidemiology of psoriatic arthritis in the population of the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Genetic epidemiology of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Histocompatibility typing in the seronegative spondyloarthropathies: a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Getting under the skin: the immunogenetics of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

A TNF-α Promoter Polymorphism Is Associated with Juvenile Onset Psoriasis and Psoriatic Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

TNFalpha polymorphisms and risk of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriasis treatment: traditional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Methotrexate use in psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Therapy with cyclosporine in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriasis pathophysiology: current concepts of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

The IL-23/IL-17 axis in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Production of type I interferons: plasmacytoid dendritic cells and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriasis with articular involvement induced by interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Misbehaving macrophages in the pathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Toll-like receptors and other links between innate and acquired alloimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

A high prevalence of parvovirus B19 DNA in patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

T-cell repertoire analysis in chronic plaque psoriasis suggests an antigen-specific immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

PSORS2 Markers Are Not Associated with Psoriatic Arthritis in the Italian Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08148.X

10.1111/J.1365-2133.2007.08148.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference